U.S. Department of Health and Human Services
Marvin Gershengorn
 

 Contact Info

 
Tel: 301-451-6305
Email: marving@mail.nih.gov
 

 Select Experience

 
  • Abby Rockefeller Mauzé Distinguished Professor of Endocrinology in MedicineCornell University Medical College1983–2001
  • Chief of the Division of Endocrinology and MetabolismCornell University Medical College1983–2001
  • Professor of Medicine and Cell Biology and GeneticsCornell University Medical College1983–2001
  • Assistant and Associate ProfessorNew York University School of Medicine1976–1983
  • M.D.New York University School of Medicine1971
  • B.S.City College of the City University of New York1967
 

 Related Links

 

    Specialties
    •  Molecular Pharmacology/Toxicology
    • Endocrinology

    ​Resources

    Patents, materials, and other research resources appear below. Some resources may be available for use through Material Transfer Agreements (MTAs) or licensing agreements.

    Resource Name Description
    Methods of identifying negative antagonists for G protein coupled receptors (U.S. Patent Number 6,087,115)

    The present invention is directed to a constitutively active G protein coupled receptor of human herpesvirus 8, as well as a method of identifying negative antagonists of a constitutively active G protein coupled receptor. The method comprises…

    (Summary)
    Methods of identifying peptide agonists or negative antagonists of a G protein coupled receptor (U.S. Patent Number 6,403,305)

    The present invention is directed to a strategy to discover small peptides that will activate any G protein coupled receptor (GPCR) or inactivate any constitutively active GPCR. The strategy uses combinatorial peptide libraries to screen millions of…

    (Summary)
    Adenovirus gene expression system (U.S. Patent Number 6,824,770)
    The invention is directed to an adenoviral vector comprising (a) at least one insertion site for cloning a heterologous gene, and, in an orientation opposite to the direction of transcription of the adenoviral region into which it is inserted, (b) a…
    (Summary)
    Low molecular weight thyroid stimulating hormone receptor (tshr) agonists (U.S. Patent Application Number WO 2010047674 A1)

    NIH investigators have discovered a series of low molecular weight thyroid-stimulating hormone (TSH) receptor modulators for use in the procedure to detect residual thyroid cancer cells following thyroidectomy. As small molecules, these compounds are…

    (Summary)
    Inverse agonists and neutral antagonists for the tsh receptor (U.S. Patent Application Number WO 2011127388 A2)

    TSHR inverse agonists and neutral antagonists that are useful for treating Graves' orbitopathy, Graves' hyperthyroidism and/or thyroid cancer.

    (Summary)
    View Additional Research Resources

    Clinical Trials

    Open studies conducted by NIDDK Principal Investigators appear below that are currently recruiting, not yet recruiting, or available for expanded access.

    Study Title
    There are no associated clinical trials.
    Search for more clinical trials at ClinicalTrials.gov